Exosens shares slip to €51.65 support, near the bottom of the SBF 120
The Bordeaux-based optronics company is sliding toward the bottom of its index, in a Parisian market that is nearly flat. The stock extends a decline that has pulled it away from all of its medium-term benchmarks.
A downturn pushes the stock below the €51.65 level and has weighed on it for several weeks
Exosens shares fell 2.68% to €50.90 intraday, while the SBF 120 remained flat (+0.01%).
The stock is the second-worst performer in the index, behind Eramet. It has dropped below the €51.65 threshold, which corresponded to its lowest level over the past 150 sessions and now acts as resistance. This level had already been tested on November 12, when the stock broke below its support.
The 12.1% decline over one month and 22.3% over three months shows that selling pressure has persisted for a long time. The RSI at 35 remains neutral and leaves room before an oversold zone.
A share price below its three moving averages, after a strong third quarter
The share price is below the MM20 at €55.49 (an 8.27% gap), the MM50 at €57.21, and the MM200 at €60.23 (a 15.49% gap). This configuration describes a stock trapped in a downtrend, with no lasting rebound since late October. It contrasts with recently published fundamentals: on October 27, the group announced revenue of €133.8 million for the third quarter, up 23.5%, with a gross margin that declined.
Over one year, the share still shows a gain of 10.65%. The next technical level to watch is resistance at €51.65, which the share price must reclaim to exit this downward zone.
